FyMed, Inc.

Press Releases

FyMed Heralds Breakthrough in the Treatment of Colon Cancer with Novel Drug Candidate FY405B

Scientists at FyMed, Inc. have identified a novel drug target in the management of colon cancer, developing a candidate that has shown significant promise for the treatment of this difficult-to-treat disease in early studies. Read More...